LDOC1 Antikörper
-
- Target Alle LDOC1 Antikörper anzeigen
- LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser LDOC1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Dot Blot (DB)
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- Leucine Zipper, Down-regulated in Cancer 1 (LDOC1, BCUR1, Mar7, Mart7)
- Aufreinigung
- Purified by Protein G affinity chromatography.
- Immunogen
- Partial sequence of recombinant full-length protein to human Leucine Zipper, Down-regulated in Cancer 1
- Klon
- 8C209
- Isotyp
- IgG2a
- Top Product
- Discover our top product LDOC1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.4, 1 % BSA, 0.05 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))
- Andere Bezeichnung
- Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1 Produkte)
- Synonyme
- BCUR1 antikoerper, Mar7 antikoerper, Mart7 antikoerper, RGD1565644 antikoerper, Gm366 antikoerper, LDOC1 antikoerper, LDOC1, regulator of NFKB signaling antikoerper, regulator of NFKB signaling antikoerper, LDOC1 antikoerper, Ldoc1 antikoerper
- NCBI Accession
- NM_012317
-